Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.
Per Med
; 20(4): 305-319, 2023 07.
Article
en En
| MEDLINE
| ID: mdl-37623911
ABSTRACT
The implementation of adequate financing and reimbursement of personalized medicine (PM) in Europe is still turbulent. The views and experience of stakeholders about barriers in financing and reimbursing PM and potential solutions were elicited and supplemented with literature findings to draft a set of recommendations. Key recommendations to overcome the barriers for adequately financing and reimbursing PM in different healthcare systems in Europe included the provision of legal foundations and establishment of large pan-European databases, use of financial-based agreements and regulation of transparency of prices and reimbursement, and creating a business-friendly environment and attractive market for innovation. The recommendations could be used by health authorities for designing a sequence of policy steps to ensure the timely access to beneficial PM.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Medicina de Precisión
/
Motivación
Tipo de estudio:
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
Aspecto:
Implementation_research
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Per Med
Año:
2023
Tipo del documento:
Article
País de afiliación:
Reino Unido